This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

81/100

✓ Peer-reviewed alzhub usefulness score 81 out of 100. Cognitive tests and assessment

Topic: Risk, prevention and care in population studies

Background Prevention of cognitive impairment and dementia is an important public health goal. Epidemiological evidence shows a relationship between cognitive impairment and Type 2 diabetes mellitus. The risk of dementia increases with duration of disease.

Key findings

Epidemiological evidence shows a relationship between cognitive impairment and Type 2 diabetes mellitus.
The risk of dementia increases with duration of disease.
This updated systematic review investigated the effect on cognitive function of the type of treatment and level of metabolic control in people with Type 2 diabetes.
Objectives To assess the effects of different strategies for managing Type 2 diabetes mellitus on cognitive function and the incidence of dementia.

Why it matters

This systematic review assessed whether different strategies for managing Type 2 diabetes affect cognitive function and the incidence of dementia, based on evidence linking diabetes to cognitive impairment. The provided text does not report the results, so it is unknown whether any diabetes treatment approach reduces dementia risk.

Study details

Study designsystematic review
Participants11,140
Effect sizeRR 0.98; RR 1.27; RR 2.18
Evidence strengthHigh

How this study scored 81/100

Published in a leading specialty journal, and it is a systematic review of all the studies on the question. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited and senior author's track record, so those were left out: it earned 55 of the 68 points we could judge it on, which is 81 out of 100.

Component	Points	Why
Journal tier	9 / 10	Tier 2 — leading specialty journal (The Cochrane database of systematic reviews)
Journal's citation record	3 / 4	Cochrane Database of Systematic Reviews: journal h-index 468 (OpenAlex, 2026-10-29)
Study design	12 / 12	A systematic review of all the studies on the question
Strength of evidence	5 / 5	Rated “high” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	2 / 5	2017 — within 10 year(s) of the newest study here
Sample size	4 / 4	11,140 participants
Effect reported	3 / 3	Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people	3 / 3	Studied in people (participant count stated)
Randomised / blinded	0 / 2	A review of other studies — randomisation is not credited here
Times cited	— / 7	Citation count not trusted: 8 of 19 library studies citing it were published more than a year before it - a sign OpenAlex merged several works under this DOI — left out of this score
Citations per year	— / 5	Citation count not trusted (see above) — left out of this score
Impact for its field and year	— / 6	Citation count not trusted (see above) — left out of this score
Cited by studies here	— / 6	Library citations not trusted (see above) — left out of this score
Still being cited	— / 4	Citation count not trusted (see above) — left out of this score
Senior author's track record	— / 4	Senior author's record not available — left out of this score
Institution's track record	0 / 3	Hospital Universitario de Getafe: institution h-index 241 (OpenAlex)
Multi-centre collaboration	2 / 3	OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 28617932)
Free to read	0 / 2	Behind a paywall — scores zero
Points	55 / 68	Scored on 14 of 20 parts. We have no data for the rest, so they are left out: 55 of the 68 points we could judge it on is 81 out of 100.
Total	81 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Areosa Sastre, A., Vernooij, R. W., González-Colaço Harmand, M., & Martínez, G. (2017). Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd003804.pub2

Vancouver

Areosa Sastre A, Vernooij RW, González-Colaço Harmand M, Martínez G. Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane database of systematic reviews. 2017. doi:10.1002/14651858.cd003804.pub2. PMID: 28617932.

BibTeX

@article{areosasastre2017-28617932,
  author  = {Areosa Sastre, A. and Vernooij, R. W. and González-Colaço Harmand, M. and Martínez, G.},
  title   = {{Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia}},
  journal = {The Cochrane database of systematic reviews},
  year    = {2017},
  doi     = {10.1002/14651858.cd003804.pub2},
  pmid    = {28617932},
  url     = {https://doi.org/10.1002/14651858.cd003804.pub2}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 35.

Later studies that cite this one

19 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Cognitive tests and assessment

Also tagged “cognitive-function”

1,118 studies in the library carry the topic tag “cognitive-function”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,118 tagged studies.

Similar studies

More on Cognitive tests and assessment

See all studies in Cognitive tests and assessment →